ECCMID 2023, the 33rd European Congress of Clinical Microbiology & Infectious Diseases, has come to an end and what a success it has been! 12 of our LMM colleagues were present to share the findings of their research en represent different project consortia:  


  • Biljana Kakaraskoska Boceska: External quality assessment within central and eastern European countries participating in LAB-Net to prepare for clinical trials

  • Thomas van der Schalk: Collateral fitness and pathogenicity effects on Pseudomonas aeruginosa after antibiotic exposure

  • Qiang Lin: Geospatial factors preeminently shape the global genome profiles of Staphylococcus aureus ST398


  • Mathias Smet: Mutations in SARS-CoV-2 genomes in COVID-19 patients receiving monoclonal antibody treatments

  • Matilda Berkell: Evolutionary dynamics and clinical impact of SARS-CoV-2 lineages in European COVID-19 cohorts



  • Juan Pablo Rodriguez Ruiz: Streptococcus pneumoniae genotypes 23B0 and 23B1 show distinct genomic characteristics and evidence of parallel non-convergent evolution

  • Lara Dierckx: Dynamics of pneumococcal 23B1 subtype carriage, associated penicillin non-susceptibility, and invasiveness in Belgium 

  • Sahaya Glingston Rajakani: Evaluation of various antibiotic combinations by in vitro time-kill assays against colistin-heteroresistant Klebsiella pneumoniae

  • Sam Van Goethem: Whole genome sequencing as a tool for outbreak management during a Serratia marcescens outbreak on a NICU in a Belgian hospital

  • Sien De Koster: Genome-wide associations identify genetic markers for fluoroquinolone resistance levels in Escherichia coli from livestock animals